Qiang Fu

High Impact

Assistant Research Professor

Last publication 2025 Last refreshed 2026-04-18

faculty

Internal Med, College of Medicine

25 h-index 61 pubs 2,894 cited

Biography and Research Information

OverviewAI-generated summary

Qiang Fu's research investigates mechanisms of bone loss and regeneration, with a particular focus on the cellular and molecular factors influencing bone health. His work has explored the role of non-coding RNAs, such as LncRNA ROR and miR-145-5p, in regulating osteoblast proliferation and apoptosis, processes critical for maintaining bone mass in conditions like osteoporosis. Fu has also examined the impact of specific protein expressions, like osteoprotegerin, on bone resorption dynamics, especially in the context of treatment discontinuation for conditions such as denosumab-induced osteoporosis.

Further studies by Fu delve into the cellular components of bone, refining the identification of mesenchymal cell types within murine periosteal and endosteal regions. His research extends to the effects of external factors on bone metabolism, including the impact of ionizing radiation on osteoclast mitochondrial function and subsequent bone loss in mice. Investigations into autophagy, specifically the loss of chaperone-mediated autophagy, have also been linked to reduced vertebral cancellous bone mass in his work. Fu's broader interests include the role of short-chain fatty acids in metabolic syndrome, with an emphasis on their influence on immunity and inflammation, and the interplay between gut microbiota and blood cell counts in patients with immune thrombocytopenia.

Metrics

  • h-index: 25
  • Publications: 61
  • Citations: 2,894

Selected Publications

  • Mechanisms of mitochondrial reactive oxygen species action in bone mesenchymal cells (2025)
    2 citations DOI OpenAlex
  • Potent suppression of bone remodeling by denosumab does not blunt the anabolic response to romosozumab in mice (2025)
    2 citations DOI OpenAlex
  • Sirtuin-3 promotes osteoclast maturation and bone loss by regulating mitochondrial ROS production during ionizing radiation exposure (2025)
    1 citation DOI OpenAlex
  • Mechanisms of mitochondrial reactive oxygen species action in bone mesenchymal cells (2025)
  • Mitochondrial oxidative stress or decreased autophagy in osteoblast lineage cells is not sufficient to mimic the deleterious effects of aging on bone mechanoresponsiveness (2025)
    4 citations DOI OpenAlex
  • Refining the identity of mesenchymal cell types associated with murine periosteal and endosteal bone (2024)
    24 citations DOI OpenAlex
  • A framework for defining mesenchymal cell types associated with murine periosteal and endosteal bone (2023)
    1 citation DOI OpenAlex
  • Reduced osteoprotegerin expression by osteocytes may contribute to rebound resorption after denosumab discontinuation (2023)
    46 citations DOI OpenAlex
  • A Rab33b missense mouse model for Smith-McCort dysplasia shows bone resorption defects and altered protein glycosylation (2023)
    2 citations DOI OpenAlex
  • Loss of chaperone-mediated autophagy is associated with low vertebral cancellous bone mass (2022)
    12 citations DOI OpenAlex
  • Ionizing Radiation Activates Mitochondrial Function in Osteoclasts and Causes Bone Loss in Young Adult Male Mice (2022)
    21 citations DOI OpenAlex

View all publications on OpenAlex →

Grants & Funding

  • Synergistic Radioprotection of Gastrointestinal Tract by Gamma-Tocotrienol (GT3) and Statins: Efficacy and Mechanisms Uniformed Services University of the Health Sciences - Pass Through: Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. Co-Investigator
  • Evaluation of IPW-5371, a TGFRI kinase inhibitor, dosed as a single agent or in combination with G-CSF, as a medical countermeasure against the delayed effects of total body irradiation in mice - Continuation NIH/Nat. Inst. of Allergy & Infectious Diseases - Pass Through: Innovation Pathways Principal Investigator
  • Osteocyte Control of Bone Remodeling NIH/Nat. Inst. of Arthritis & Musculoskeletal & Skin Diseases Principal Investigator
  • Osteocyte Control of Bone Remodeling NIH/Nat. Inst. of Arthritis & Musculoskeletal & Skin Diseases Co-Investigator
  • Advanced Development of Gamma-Tocotrienol as a Radiation Countermeasure US Department of Defense - Pass Through: Armed Forces Radiobiology Research Institute Co-Investigator
  • Center for Musculoskeletal Disease Research (CMDR) NIH/Nat. Inst. of General Medical Sciences Principal Investigator
  • Endonuclease-targeted radioprotection NIH/Nat. Inst. of Allergy & Infectious Diseases - Pass Through: Duke University Co-Investigator
  • Center for Musculoskeletal Disease Research (CMDR) NIH/Nat. Inst. of General Medical Sciences Principal Investigator

Collaboration Network

133 Collaborators 34 Institutions 3 Countries

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics